Screener
Acadia Pharmaceuticals ACAD Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Acadia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The source filing: Acadia Pharmaceuticals’s 10-Q, filed August 5, 2026.
- Filed
- Aug 4, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333243
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Stockholders’ equity: | ||
| Preferred stock, $0.0001 par value; 5,000,000 shares authorized at June 30, 2026 and December 31, 2025; no shares issued and outstanding at June 30, 2026 and December 31, 2025 | — | — |
| Common stock, $0.0001 par value; 225,000,000 shares authorized at June 30, 2026 and December 31, 2025; 172,132,442 shares and 170,309,376 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | 16 | 16 |
| Additional paid-in capital | 3,085,800 | 3,039,315 |
| Accumulated deficit | (1,778,249) | (1,813,386) |
| Accumulated other comprehensive (loss) income | (958) | 1,445 |
| Total stockholders’ equity | 1,306,609 | 1,227,390 |
| Total liabilities and stockholders’ equity | $1,742,900 | $1,564,195 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Acadia Pharmaceuticals's total liabilities & equity?
- Acadia Pharmaceuticals (ACAD) reported total liabilities & equity of $1.74B in Q2 2026.
- How has Acadia Pharmaceuticals's total liabilities & equity changed year-over-year?
- Acadia Pharmaceuticals's total liabilities & equity increased by 42.2% year-over-year, from $1.23B to $1.74B.
- What is the long-term trend for Acadia Pharmaceuticals's total liabilities & equity?
- Over 5 years (2020 to 2025), Acadia Pharmaceuticals's total liabilities & equity has grown at a 14.9% compound annual growth rate (CAGR), from $782.62M to $1.56B.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.
Ask your AI about Acadia Pharmaceuticals's total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude